NeuBase Therapeutics

+$0.0244 (+2.53%) As of 6:10 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NBSE and other ETFs, options, and stocks.

About NBSE

NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines.

CEO
Dietrich A. Stephan
Employees
33
Headquarters
Pittsburgh, Pennsylvania
Founded
2009

NBSE Key Statistics

Market cap
31.94M
Price-Earnings ratio
—
Dividend yield
—
Average volume
48.21K
High today
$1.03
Low today
$0.97
Open price
$0.97
Volume
56.05K
52 Week high
$5.51
52 Week low
$0.89

NBSE Earnings

-$0.30
-$0.20
-$0.10
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
-$0.30 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure